↓ Skip to main content

Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma

Overview of attention for article published in Biomarker Research, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

blogs
1 blog
twitter
1 X user

Readers on

mendeley
35 Mendeley